MPR Weekly Dose

This week we run through the latest COVID-19 news including the shortage of critical meds, The CDC U-turn on face mask recommendations, Remdesivir trial enrollment, testing for COVID-19 antibodies, and new guidance from the FDA on blood donations aimed at helping maintain the supply. 

This episodes covers the latest COVID-19 news including drug shortages, a new point-of-care diagnostic tool, the role of vitamin C, misuse of non-pharmacological chloroquine, and also some big news about a popular heartburn drug.

This week we talk about the latest on COVID-19, including the virus in relation to NSAID use; the pandemics knock on effect on drug shortages; a safety alert for fecal microbiota transplants; and potential flaws in EpiPen devices.

This week we talk about a phase 1 vaccine trial for COVID-19 underway in Seattle; Concerns over COVID-19 and ACE inhibitor, ARB use; Safety labeling changes for SGLT2 inhibitors; A biosimilar to Herceptin; And new graphic warnings for cigarette packages.

Today we talk about the latest COVID-19 news; New approvals for chronic fibrosing interstitial lung diseases and Cushing disease; and stronger safety warnings for montelukast.

Today we talk about the ban on certain electrical stimulation devices, the latest COVID-19 news, a first generic of Daraprim, a New Drug Application for a potential microneedle migraine treatment patch, and a first over-the-counter combination of ibuprofen and acetaminophen: Advil Dual Action.

This week on the pod we cover a first-in-class cholesterol lowering therapy; a new indication for Trulicity; Macrolide prescriptions in the first trimester and their relation to fetal malformations; a new fragile X diagnostic test; and a migraine prevention IV treatment.

This week on the pod we cover the withdrawal of Belviq, the weight-loss drug, from the market; the over-the-counter approval of diclofenac gel and olopatadine eye drops; a new contraceptive transdermal patch; a possible vaccine for ricintoxin; and new research finds that hundreds of sellers are using Craigslist to sell prescribing medications.

This week on the pod we cover an insulin pump recall; Pharmacies running out of supplies in light of Covid-19 fears; Investigational Alzheimer disease treatments not meeting trial end points; A new cardiac ultrasound device; and a new oral testosterone replacement therapy.

This week on the Pod we cover the approval of the first oral therapy for peanut allergy; The 2020 immunization schedule; The latest on the coronavirus, including the CDC's shipment of test kits; The withdrawal of an antibiotic; and results from the FDA investigation into possible impurities in metformin.

This week we discuss the latest news surrounding the novel coronavirus, including the WHO's decision to declare the virus a global emergency; A new triple combo therapy in type 2 diabetes; Updated Tdap vaccination recommendations; An FDA warning regarding serious clozapine side effects; And news of possible cybersecurity vulnerabilities with certain patient monitoring devices.

This week we cover the CDC coronavirus health advisory; A possible oral influenza vaccine; A new treatment to reduce the risk of MACE; An FDA Committee vote; And the first approved treatment for thyroid eye disease.

This week we cover the approval of a cocaine nasal solution; 23andMe's entry into the drug development; The recall of an epilepsy and bipolar treatment; A new nasal spray for seizure patients; And the weight loss drug that may be linked to cancer.

In our first episode of 2020 we cover new management guidelines in osteoarthritis; Recommendations for the use of testosterone therapy; The best diets for 2020; Two drug recalls; And a new drug approved for the treatment of migraines.

Back from our Thanksgiving break, this week we talk about the new approval for sickle cell disease; the re-introduction of a product that was taken off the market in the 60's; The first ready-to-use phenylephrine injection; A new ultrasound enhancing agent; And an approval for arthritis.

MPR Weekly Dose Podcast: Episode 14 by MPR Weekly Dose

This week on the Weekly Dose we talk about the first lung transplant due to vaping-related illness; A new approval for patients with beta thalassemia; Opioids in osteoarthritis; A new, free test to help diagnose COPD; and news of a potential new therapy for hypercholesterolemia.

This week we talk about NDMA findings in ranitidine products; Approval of a new flu vaccine; The return of an antiarrhythmic agent; A new treatment for H. pylori infection; and the risk of biotin interference in test results which could lead to missed diagnoses.

This week we talk about the recall of an anti-anxiety med; Possible withdrawal of Makena; New MS treatment approved; IUD approved for up to six years; and time of day when meds taken could affect CVD risk.

This week we talk about the resurrection of Biogen's novel Alzheimer treatment; A "landmark" approval in cystic fibrosis; Expanded indication for Farxiga; The first topical minocycline formulation for acne vulgaris; and the Johnson's baby powder recall.

This week we talk about new treatment approvals for acute migraine, dry eye disease and schizophrenia; a new indication for Xarelto; and the Centers for Disease Control and Prevention issue an interim guidance for physicians regarding electronic cigarette, or vaping, product use-associated lung injury, or 'EVALI'.

This week we talk about the FDA highlighting THC in the recent spate of vaping-related illnesses; Descovy's expanded approval; A new cream for acne; A treatment for the rare condition possibly behind the creation of vampire myths; and a new drug approval for the treatment of wet age-related macular degeneration.

This week: New Invokana approval; More ranitidine recalls lead CVS to suspend all sales; FDA has identifies 11 serious cybersecurity vulnerabilities that could affect medical devices and hospital networks; Entresto indication expanded; and COPD investigate treatment is rejected.

This week: A new tablet treatment for type 2 diabetes; Pancreatitis treatment gains Orphan Drug status; New approval for smallpox, monkeypox; An investigational treatment for Guillain-Barré Syndrome; and big changes at e-cigarette maker, Juul.

This week: FDA votes on possible peanut allergy treatment; New risks ID'd with some breast cancer drugs; a topical solution for common warts edges nearer; Nitrosamine impurity identified in acid suppressant; And news of another e-cigarette related fatality.